Autocrine differentiation of PC12 cells mediated by retroviral vectors

• Published in: Developmental neuroscience Vol. 12; no. 1; p. 34
• Main Authors: Short, M P, Rosenberg, M B, Ezzedine, Z D, Gage, F H, Friedmann, T, Breakefield, X O
• Format: Journal Article
• Language: English
• Published: Switzerland 1990
• Subjects: Animals; beta-Galactosidase - genetics; Cells, Cultured; DNA, Recombinant; Galactosidases - genetics; Genetic Vectors; Nerve Growth Factors - genetics; Nerve Growth Factors - metabolism; Pheochromocytoma; Rats; Retroviridae - genetics; Tumor Cells, Cultured - cytology; Tumor Cells, Cultured - metabolism; Tumor Cells, Cultured - microbiology
• ISSN: 0378-5866
• DOI: 10.1159/000111833

Rat pheochromocytoma PC12 cells have been modified genetically by the use of replication-defective retroviral vectors containing either the bacterial gene for beta-galactosidase (lac Z) or cDNAs for mouse beta-nerve growth factor (NGF) and the bacterial gene for neomycin resistance. Using the lac Z vector, clonal lines of PC12 cells were obtained in which almost 100% of cells stably expressed this histochemical marker. Infection of PC12 cells or the derived subclone PC12-BAG, which expresses beta-galactosidase, with the NGF vectors resulted in autocrine differentiation as assessed by extensive neurite formation, which occurred within hours after infection and was maintained for weeks in culture. Neurite formation could be partially blocked by antibodies to NGF. The percentage of cells expressing neurite outgrowth was greater than that of PC12 cells treated with exogenous NGF. PC12 cells infected with the NGF vectors were shown to release this trophic factor into the medium using a two-site enzyme immunoassay and a bioassay on 'naive' PC12 cells. PC12 cells genetically modified using these vectors provide a means to: follow the fate of the cells after transplantation into animals; test for delivery in vivo of NGF and catecholamines by grafted, autocrine-differentiated PC12 cells; and study the long-term actions of NGF on responsive cells without adding exogenous NGF.